 Shares of INVO Bioscience, Inc. NASDAQ: INVO gained more than 202 in the regular trading session on Tuesday. What Happened: The sharp gains came after the Sarasota, Massachusetts-based medical device company said it has amended its exclusive U.S. commercialization agreement with Ferring Pharmaceuticals. 